Oral induction therapy with obefazimod (Abivax) for 8 weeks led to clinically meaningful improvements across all efficacy endpoints in a highly refractory population of patients with moderately to ...

Results from a recent study suggest a potential benefit from bariatric surgery in patients with IBD and obesity. Maintaining Remission and Preventing Relapse in Patients Hospitalized for Severe or ...

July 3, 2003 — Infliximab is not helpful for treating patients with steroid-refractory ulcerative colitis, according to the results of a randomized controlled trial published in the July issue of Gut.

(RTTNews) - Johnson & Johnson (JNJ) announced Thursday TREMFYA (guselkumab) data in both Crohn's disease (CD) and ulcerative colitis (UC) showing high rates of endoscopic remission in both ...

Most patients with inflammatory bowel disease (IBD) respond to initial therapy, but an estimated 10% to 40% don't, and some others become resistant to treatment over long periods of time. For many ...

SAN FRANCISCO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of ...

Why Do People Get a Colonoscopy for Ulcerative Colitis? Ulcerative colitis is a type of inflammatory bowel disease that causes inflammation and sores to form in the large intestine and rectum. It ...